Your browser doesn't support javascript.
loading
Successful infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in two Taiwanese children: An experience from a medical center.
Liu, Chun-Ting; Luxton, G W Gant; Sung, Chia-Cheng; Wang, Fu-Min; Chang, Chia-Ning; Hu, Chih-Fen.
Afiliación
  • Liu CT; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Luxton GWG; Department of Molecular and Cellular Biology, University of California-Davis, Davis, CA, USA.
  • Sung CC; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Wang FM; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Chang CN; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Hu CF; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC. Electronic address: caperhu@gmail.com.
Pediatr Neonatol ; 65(3): 305-307, 2024 May.
Article en En | MEDLINE | ID: mdl-38169192

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Respuesta Inflamatoria Sistémica / Infliximab / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Child / Humans País/Región como asunto: Asia Idioma: En Revista: Pediatr Neonatol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Respuesta Inflamatoria Sistémica / Infliximab / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Child / Humans País/Región como asunto: Asia Idioma: En Revista: Pediatr Neonatol Año: 2024 Tipo del documento: Article